Wednesday, November 20, 2024
HomeIndustriesHealthcare

Healthcare

Innovent and Etana Jointly Announce the Approval of Bevagen by the Indonesian Food and Drugs Authority (BPOM)

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer

Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for unmet needs in cancer, announced the initiation of patient dosing in TWT-203, its Phase...

Hollister Incorporated Receives Vizient Contract for Urological Products

Hollister Incorporated, a global medical device company, has been awarded a three-year group purchasing agreement for Urological products with vizient, Inc., the nation's largest...

Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement

Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...

BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO

BioMarin Pharmaceutical Inc. presented data at The Endocrine Society Annual Meeting, ENDO 2022, demonstrating the Company's ongoing commitment to understanding the lifetime impact of...
0FansLike
0FollowersFollow
spot_img

Hot Topics